ARTELO BIOSCIENCES, INC.
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
ARTL$2.14+3.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets at December 31, 2025 and 2024
Consolidated Balance Sheets
(In thousands, except share data)
| December 31, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| ASSETS | ||
| Current Assets | ||
| Cash and cash equivalents | $600 | $2,338 |
| Prepaid expenses and other current assets | 95 | 219 |
| Total Current Assets | 695 | 2,557 |
| Operating lease right-of-use assets | 64 | 99 |
| Intangible asset | 2,039 | 2,039 |
| Other assets | 3 | 3 |
| TOTAL ASSETS | $2,801 | $4,698 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | $3,035 | $1,676 |
| Due to related parties | 345 | 61 |
| Operating lease liabilities - current portion | 40 | 35 |
| Accrued interest - convertible notes | 11 | - |
| Accrued interest – convertible notes – related party | 4 | - |
| Convertible notes | 437 | - |
| Convertible notes – related party | 172 | - |
| Total Current Liabilities | 4,044 | 1,772 |
| Operating lease liabilities | 29 | 69 |
| TOTAL LIABILITIES | 4,073 | 1,841 |
| STOCKHOLDERS' EQUITY | ||
| Preferred Stock, par value $0.001, 69,444 shares authorized, 0 shares issued and outstanding as of December 31, 2025, and 2024 | - | - |
| Common Stock, par value $0.001, 500,000,000 shares authorized and 2,018,746 and 567,582 shares issued and outstanding as of December 31, 2025, and 2024, respectively | 2 | 1 |
| Additional paid-in capital | 62,013 | 53,194 |
| Accumulated deficit | (63,015) | (50,136) |
| Accumulated other comprehensive loss | (272) | (202) |
| TOTAL STOCKHOLDERS' (DEFICIT) EQUITY | (1,272) | 2,857 |
| TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY | $2,801 | $4,698 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.